Changing epidemiology of bacterial meningitis in the United States
- 1 July 2000
- journal article
- research article
- Published by Springer Nature in Current Infectious Disease Reports
- Vol. 2 (4) , 327-331
- https://doi.org/10.1007/s11908-000-0011-2
Abstract
Bacterial meningitis is an important cause of morbidity and mortality in the United States and throughout the world. Over the past 20 years, there have been significant changes in the epidemiology of bacterial meningitis. The most important change is the decrease in the frequency of Haemophilus influenzae type b as the most common etiologic agent of bacterial meningitis, since the H. influenzae type b conjugate vaccine was introduced. Streptococcccus pneumoniae is now the major cause of bacterial meningitis in the US and bacterial meningitis is now a disease predominantly of adults, rather than of infants and children. Emergence of antimicrobial resistance in S. pneumoniae has also altered the approach to antimicrobial therapy in patients with pneumococcal meningitis, indicating the need to use preventive strategies to reduce the frequency of this serious infection. Recent licensure of the heptavalent pneumococcal conjugate vaccine will likely decrease the overall incidence of pneumococcal meningitis.Keywords
This publication has 27 references indexed in Scilit:
- Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in childrenThe Pediatric Infectious Disease Journal, 2000
- Clonally Related Penicillin-Nonsusceptible Streptococcus pneumoniae Serotype 14 from Cases of Meningitis in Salvador, BrazilClinical Infectious Diseases, 2000
- Recommended Childhood Immunization Schedule---United States, January-December 2000Published by American Academy of Pediatrics (AAP) ,2000
- EMERGENCE OF DRUG RESISTANCE: Impact on Bacterial MeningitisInfectious Disease Clinics of North America, 1999
- Spread of Drug‐ResistantStreptococcus pneumoniaein Asian Countries: Asian Network for Surveillance of Resistant Pathogens (ANSORP) StudyClinical Infectious Diseases, 1999
- Drug‐ResistantStreptococcus pneumoniaeClinical Infectious Diseases, 1998
- Bacterial Meningitis in the United States in 1995New England Journal of Medicine, 1997
- The 1996 Albert Lasker Medical Research Awards. Prevention of systemic infections, especially meningitis, caused by Haemophilus influenzae type b. Impact on public health and implications for other polysaccharide-based vaccinesJAMA, 1996
- The Prevalence of Drug-ResistantStreptococcus pneumoniaeIn AtlantaNew England Journal of Medicine, 1995
- The clinical spectrum of bacterial meningitisThe American Journal of Medicine, 1962